Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Circulating glucagon-like peptide-1 increases in response to short-term overfeeding in men.

Wadden D, Cahill F, Amini P, Randell E, Vasdev S, Yi Y, Church J, Sun G.

Nutr Metab (Lond). 2013 Apr 8;10(1):33. doi: 10.1186/1743-7075-10-33.

2.

Serum acylated ghrelin concentrations in response to short-term overfeeding in normal weight, overweight, and obese men.

Wadden D, Cahill F, Amini P, Randell E, Vasdev S, Yi Y, Zhang W, Sun G.

PLoS One. 2012;7(9):e45748. doi: 10.1371/journal.pone.0045748. Epub 2012 Sep 27.

3.

Short-term overfeeding increases circulating adiponectin independent of obesity status.

Cahill F, Amini P, Wadden D, Khalili S, Randell E, Vasdev S, Gulliver W, Sun G.

PLoS One. 2013 Aug 30;8(8):e74215. doi: 10.1371/journal.pone.0074215. eCollection 2013.

4.

Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normal-weight, overweight, and obese men.

Shea J, Randell E, Vasdev S, Wang PP, Roebothan B, Sun G.

Am J Clin Nutr. 2007 Nov;86(5):1310-5.

5.

Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men.

Sun G, Bishop J, Khalili S, Vasdev S, Gill V, Pace D, Fitzpatrick D, Randell E, Xie YG, Zhang H.

Am J Clin Nutr. 2007 Feb;85(2):399-404.

6.

Altered circulating concentrations of active glucagon-like peptide (GLP-1) and dipeptidyl peptidase 4 (DPP4) in obese subjects and their association with insulin resistance.

Ahmed RH, Huri HZ, Muniandy S, Al-Hamodi Z, Al-Absi B, Alsalahi A, Razif MF.

Clin Biochem. 2017 Sep;50(13-14):746-749. doi: 10.1016/j.clinbiochem.2017.03.008. Epub 2017 Mar 11.

PMID:
28288852
7.

GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects.

Fernández-García JC, Murri M, Coin-Aragüez L, Alcaide J, El Bekay R, Tinahones FJ.

Clin Endocrinol (Oxf). 2014 May;80(5):671-6. doi: 10.1111/cen.12221. Epub 2013 May 6.

PMID:
23573808
8.

Fasting glucagon-like peptide-1 and its relation to insulin in obese children before and after weight loss.

Reinehr T, de Sousa G, Roth CL.

J Pediatr Gastroenterol Nutr. 2007 May;44(5):608-12.

PMID:
17460495
9.

The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.

Lee A, Patrick P, Wishart J, Horowitz M, Morley JE.

Diabetes Obes Metab. 2002 Sep;4(5):329-35.

PMID:
12190996
10.

Changes in the transcriptome of abdominal subcutaneous adipose tissue in response to short-term overfeeding in lean and obese men.

Shea J, French CR, Bishop J, Martin G, Roebothan B, Pace D, Fitzpatrick D, Sun G.

Am J Clin Nutr. 2009 Jan;89(1):407-15. doi: 10.3945/ajcn.2008.25970. Epub 2008 Dec 3.

11.

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.

J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13.

PMID:
12788877
12.

Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease.

Yamaoka-Tojo M, Tojo T, Takahira N, Matsunaga A, Aoyama N, Masuda T, Izumi T.

Cardiovasc Diabetol. 2010 May 14;9:17. doi: 10.1186/1475-2840-9-17.

13.
14.

Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects.

Velasquez-Mieyer PA, Cowan PA, Umpierrez GE, Lustig RH, Cashion AK, Burghen GA.

Int J Obes Relat Metab Disord. 2003 Nov;27(11):1359-64.

15.

Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.

Hussein MS, Abushady MM, Refaat S, Ibrahim R.

Arch Med Res. 2014 Jan;45(1):58-62. doi: 10.1016/j.arcmed.2013.10.012. Epub 2013 Dec 7.

PMID:
24321596
16.

Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.

de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O.

Ann Nutr Metab. 2007;51(2):134-8. Epub 2007 May 29.

PMID:
17536190
17.

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.

Verdich C, Toubro S, Buemann B, Lysgård Madsen J, Juul Holst J, Astrup A.

Int J Obes Relat Metab Disord. 2001 Aug;25(8):1206-14.

PMID:
11477506
18.
19.

Clinical aspects of leptin.

Sinha MK, Caro JF.

Vitam Horm. 1998;54:1-30. Review.

PMID:
9529971
20.

Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.

Lugari R, Dei Cas A, Ugolotti D, Barilli AL, Camellini C, Ganzerla GC, Luciani A, Salerni B, Mittenperger F, Nodari S, Gnudi A, Zandomeneghi R.

Horm Metab Res. 2004 Feb;36(2):111-5.

PMID:
15002062

Supplemental Content

Support Center